U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Postmarketing Adverse Event Reporting for Nonprescription Human Drug Products Marketed Without an Approved Application
  1. Regulatory Information

GUIDANCE DOCUMENT

Postmarketing Adverse Event Reporting for Nonprescription Human Drug Products Marketed Without an Approved Application July 2009

Final

Postmarketing Adverse Event Reporting for Nonprescription Human Drug Products Marketed Without an Approved Application

Issued by:
Guidance Issuing Office
Center for Drug Evaluation and Research

This document provides guidance to industry on postmarketing serious adverse event reporting for nonprescription (over-the-counter (OTC)) human drug products marketed without an approved application. In particular, this document gives guidance on (1) the minimum data elements that should be included in a serious adverse event report, (2) the label that should be included with the report, (3) reporting formats for paper and electronic submissions, and (4) how and where to submit the reports.
 


Submit Comments

Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)

If unable to submit comments online, please mail written comments to:

Division of Dockets Management (HFA- 305)
Food and Drug Administration
5630 Fishers Lane, Rm. 1061
Rockville, MD 20852

All comments should be identified with the title of the guidance.